Medical cannabis, still seeking both cures and acceptance - Rize ETF

As medical cannabis gains acceptance across Europe, it leads the way for the industry – and sets the stage for recreational, adult-use acceptance.

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

... The coming year is expected to be vital for growth in the medical cannabis market, with accelerating expansion to legal access, rising rates of consumption and social acceptance, and increased capitalisation of commercial operations. Rize ETF expect the total number of European medical cannabis patients to increase by over 33% (from approximately 130,000 in 2021 to 174,000 in 2022), with the number due to exceed 300,000 during 2025.

Learn more here